Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid‐induced apoptosis

@article{Tonko2001GeneEP,
  title={Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid‐induced apoptosis},
  author={M. Tonko and Michael J. Ausserlechner and David Bernhard and Arno Helmberg and Reinhard Kofler},
  journal={The FASEB Journal},
  year={2001},
  volume={15},
  pages={693 - 699}
}
Glucocorticoids (GC) have pronounced effects on metabolism, differentiation, proliferation, and cell survival (1). In certain lymphocytes and lymphocyte‐related malignancies, GC inhibit proliferation and induce apoptotic cell death, which has led to their extensive use in the therapy of malignant lymphoproliferative disorders (2). Most of these effects result from regulation of gene expression via the GC receptor (GR), a ligand‐activated transcription factor (3). Although hundreds of genes are… 
Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia
Identification of genes leading to glucocorticoid-induced leukemic cell death
TLDR
Gene microarray analysis found the network of genes involved in GC-evoked cell death, using three clones derived from the CEM lymphoid leukemia cell line, and suggested that primary gene targets for GC often lack a classic GC response element.
Granzyme A mediates glucocorticoid‐induced apoptosis in leukemia cells
TLDR
Results showed that granzyme A is critically involved in mediating the apoptotic effect of glucocorticoid on leukemia cells, and the granzyme inhibitor 3,4‐dichloroisocoumarin inhibited the dexamethasone‐induced apoptosis of 697 cells in a concentration‐dependent manner.
Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells
TLDR
It is suggested that repression of both, c-myc and cyclin D3, is necessary to arrest human leukemia cells in the G1 phase of the cell division cycle, but that neither one is required for GC-induced apoptosis.
Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis
TLDR
Several genes were found to be regulated that may contribute to synergistic action of glucocorticoid component of chemotherap#y protocols with other components of frequently used chemotherapy protocols such as antimetabolites, methotrexate and alkylating agents.
Gene networks in glucocorticoid-evoked apoptosis of leukemic cells
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 31 REFERENCES
The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels.
TLDR
It is implied that p16(INK4A) inactivation, in addition to allowing unrestricted proliferation, represents a mechanism by which lymphoid tumor cells might escape cell death triggered by endogenous GC.
The Cell Cycle Inhibitor p16INK4A Sensitizes Lymphoblastic Leukemia Cells to Apoptosis by Physiologic Glucocorticoid Levels*
TLDR
It is found that p16INK4A-arrested cells had elevated GC receptor expression associated with enhanced GC-mediated transcriptional activity and increased responsiveness of the GC-regulated cyclin D3 gene, suggesting that lymphoid tumor cells might escape cell death triggered by endogenous GC.
Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
TLDR
Analysis of the GC-resistant human acute T-cell leukemia line CEM-C1, which has been reported to express biochemically functional GR and was thought to owe its GC resistance to signal transduction changes distal from the GR, found that it was heterozygous for the ligand binding domain L753F point mutation in exon 9.
Apoptosis: mode of cell death induced in T cell leukemia lines by dexamethasone and other agents
  • N. Bansal, A. Houle, G. Melnykovych
  • Biology, Chemistry
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 1991
TLDR
It appears that in leukemic cells apoptosis may be induced by a variety of unrelated toxic agents and is not limited to glucocorticoids.
Irradiation induces G2/M cell cycle arrest and apoptosis in p53-deficient lymphoblastic leukemia cells without affecting Bcl-2 and Bax expression
TLDR
In these, and perhaps other leukemia cells, a p53- and Bcl-2/Bax-independent mechanism is operative that efficiently senses irradiation effects and translates this signal into arrest in the G2/M phase of the cell cycle and subsequent apoptosis.
Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosis
TLDR
Bcl-2 can be placed upstream of effector caspase activation, but downstream of other GC-regulated events, such as growth arrest and the potentially critical repression of steady state levels of multiple mRNA.
Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells.
TLDR
It is suggested that basal level GR expression is inadequate to mediate glucocorticoid-induced apoptosis in glucose-sensitive T cells and that positive autoregulation is a necessary component of this process.
Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line.
TLDR
This work PCR amplified, cloned, and sequenced GC receptor (GR) transcripts and gene segments from a GC-resistant subclone of the human acute leukemic cell line CCRF-CEM, termed CEM-R6, and revealed that one GR gene allele harbored a point mutation previously shown to compromise GR functions in other CCRf-C EM derivatives.
Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts
The histone deacetylase inhibitor and potential anti‐cancer drug sodium butyrate is a general inducer of growth arrest, differentiation, and in certain cell types, apoptosis. In human CCRF‐CEM, acute
...
1
2
3
4
...